| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Gene Promoter and Salivary Cortisol Secretion1
Department of Heart and Lung Diseases (R.R., P.B.), Sahlgrenska University Hospital, S-413 45 Göteborg, Sweden; and Pennington Biomedical Research Center (R.R., M.C., C.B.), Baton Rouge, Louisiana 70808
Address all correspondence and requests for reprints to: Roland Rosmond, M.D., Ph.D., Department of Heart and Lung Diseases, Sahlgrenska University Hospital, S-413 45 Göteborg, Sweden.
The objective of the current study was to examine the potential impact
of the G
A substitution at position -308 of the tumor necrosis
factor
(TNF-
) gene promoter on obesity and
estimates of insulin, glucose, and lipid metabolism as well as
circulating hormones including salivary cortisol in 284 unrelated
Swedish men born in 1944. The subjects were genotyped by using PCR
amplification of the 5' untranslated region of the
TNF-
gene followed by digestion with the restriction
enzyme NcoI. The frequencies were 0.77 for allele
G and 0.23 for allele A. Tests for
differences in salivary cortisol levels between the
TNF-
genotypes revealed that there were significantly
higher cortisol levels in the morning, before as well as 30 and 60 min
after stimulation by a standardized lunch in homozygotes for the rare
allele in comparison with the other genotypes. In addition, homozygotes
for the rare allele had a tendency toward higher mean values of body
mass index, waist to hip ratio, and abdominal sagittal diameter
compared with the other genotype groups. The results also indicated a
weak trend toward elevated insulin and glucose levels among men with
the A/A genotype. In conclusion, a G
A polymorphism in the 5'
untranslated region of the TNF-
gene is associated
with elevated morning cortisol levels as well as elevated postprandial
cortisol secretion. This increase in cortisol secretion might be the
endocrine mechanism underlying the previously observed associations
between the NcoI TNF-
polymorphism and
obesity as well as insulin resistance. However, to what extent this
polymorphism is associated with these conditions is uncertain from the
present data.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |